FURAZABOL / MIOTOLAN
Substance: furazabol
Furazobol, known by its trade name,
Miotolan, is a synthetic derivative of dihydrotestosterone. Until 1990
this steroid was not detectable during any doping tests and could thus
be taken by athletes even on the day of a competition. When looking at
the application of Miotolan you learn even more unusual things: This
steroid is used as a lipid reducer. It is suitable for long-term
treatment of arteriosclerosis and hypercholesterolemia. Miotolan reduces
the cholesterol level and increases the "good" HDL value. In
Japan Miotolan is a standard treatment to lower cholesterol levels.
This steroid does not cause water and salt retention and does not
aromatize. Since the tablets are effective for only a brief period of
time they must be taken several times a day. Miotolan has a
predominantly androgenic effect and only a very low repression of the
body's own testosterone production. Although it is potentially hepatoxic
a possible reduced liver function seems unlikely if the daily
manufacturer-recommended dose of 2-6 mg is not exceeded. Since athletes
use considerably higher dosages the risk of liver poisoning cannot be
excluded.
This drug is produced in several Asian Labs ithese days, in tabs wih a strength of 10 mg
Compared to Stanozonol its efectiveness is better with a lower dasage.( 20 -30 mg daily ).